Login to Your Account

Other News To Note

Friday, July 19, 2013
• Betastem Therapeutics Inc., of San Francisco, said it retained Conditas Biotechnology Group LLC for its services in the area of business development and corporate strategy.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription